BD Boosts US Manufacturing of Critical Medical Devices
A $10 million investment in BD's US manufacturing network will support expanded production of critical care syringes, needles, and IV catheters.
Tag: BD Becton Dickinson
All
Latest
BD Boosts US Manufacturing of Critical Medical Devices
A $10 million investment in BD’s US manufacturing network will support expanded production of critical care syringes, needles, and IV catheters.
Read More
BD Acquires Critical Care from Edwards Lifesciences
The critical care portfolio includes the Swan Ganz pulmonary artery catheter, minimally invasive sensors, noninvasive cuffs, tissue oximetry sensors, and monitors.
Read More
Five RSV Articles for the Week
FDA panel favors approval for two RSV vaccines, ‘Tripledemic’ hits US households, and a monoclonal antibody may be ready for next season—here are five RSV stories you should check out this week.
Read More
FDA Green-lights BD’s Combo RSV, Flu, COVID Test
BD received FDA emergency use authorization for its new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and respiratory syncytial virus (RSV).
Read More
FDA Authorizes BD Veritor 15-min COVID-19 Antigen Test
The US FDA has authorized the BD Veritor Plus SARS-CoV-2 assay, a rapid, point-of-care, antigen test manufactured by Becton Dickinson.
Read More
BD Launches Wireless POC Diagnostic for Flu, RSV
The new wireless BD Veritor Plus System provides clinicians and laboratorians with rapid, lab-quality immunoassay test results for influenza A/B, RSV, and group A strep.
Read More
BD Sells Controlling Share of its Respiratory Business to Apax
BD has signed a definitive agreement to sell 50.1% of its Respiratory Solutions business to Apax Partners, as part of a plan to form a new, joint venture in the respiratory space.
Read More
BD Acquires CareFusion
Becton, Dickinson and Co has completed its acquisition of CareFusion based on its previous merger agreement to buy the company for $12.2 billion in October 2014.
Read More
BD to Buy CareFusion for $12.2 Billion
CareFusion will be purchased by Becton, Dickinson & Co for $12.2 billion, the companies announced Sunday.
Read More